These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 21528264)

  • 1. Correlation between reduced p21(WAF1/CIP1) expression and abnormal p53 expression in esophageal carcinomas.
    Toh Y; Kuwano H; Sonoda K; Saeki H; Kawaguchi H; Kitamura K; Nakashima H; Sugimachi K
    Int J Oncol; 1997 Oct; 11(4):703-8. PubMed ID: 21528264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p21(Waf1/Cip1) expression and the p53/MDM2 feedback loop in gastric carcinogenesis.
    Craanen ME; Blok P; Offerhaus GJ; Meijer GA; Dekker W; Kuipers EJ; Meuwissen SG
    J Pathol; 1999 Dec; 189(4):481-6. PubMed ID: 10629547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Cyclin-dependent Kinase Inhibitor p21(WAF1/CIP1) in Non-small Cell Lung Carcinomas: Relationship with p53 Status and Proliferative Activity.
    Myong NH
    Cancer Res Treat; 2001 Aug; 33(4):329-34. PubMed ID: 26680804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of p21(waf1/cip1) expression in non-papillomatous nasal mucosa, endophytic sinonasal papillomas, and associated carcinomas.
    Schwerer MJ; Sailer A; Kraft K; Baczako K; Maier H
    J Clin Pathol; 2001 Nov; 54(11):871-6. PubMed ID: 11684723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin D1 and p21 in ulcerative colitis-related inflammation and epithelial neoplasia: a study of aberrant expression and underlying mechanisms.
    Wong NA; Mayer NJ; Anderson CE; McKenzie HC; Morris RG; Diebold J; Mayr D; Brock IW; Royds JA; Gilmour HM; Harrison DJ
    Hum Pathol; 2003 Jun; 34(6):580-8. PubMed ID: 12827612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of p21(WAF1/CIP1) and p53 expression in serous cystadenocarcinoma of the ovary.
    Terauchi F; Okamoto A; Nagashima T; Kobayashi Y; Moritake T; Yamamoto Y; Takakura S; Iwaki S; Ogura H
    Oncol Rep; 2005 Aug; 14(2):363-8. PubMed ID: 16012716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced p21(WAF1/CIP1) protein expression is predominantly related to altered p53 in hepatocellular carcinomas.
    Shi YZ; Hui AM; Takayama T; Li X; Cui X; Makuuchi M
    Br J Cancer; 2000 Jul; 83(1):50-5. PubMed ID: 10883667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between polymorphism in p21(Waf1/Cip1) cyclin-dependent kinase inhibitor gene and human oral cancer.
    Ralhan R; Agarwal S; Mathur M; Wasylyk B; Srivastava A
    Clin Cancer Res; 2000 Jun; 6(6):2440-7. PubMed ID: 10873097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel polymorphism in p21(waf1/cip1) cyclin dependent kinase inhibitor gene: association with human esophageal cancer.
    Bahl R; Arora S; Nath N; Mathur M; Shukla NK; Ralhan R
    Oncogene; 2000 Jan; 19(3):323-8. PubMed ID: 10656678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance and expression of p53, p21(Cip1/WAF1) and Gadd45α in breast neoplasm tissues].
    Gao QZ; Fei BJ; Qi XW; Pu Y; Feng YZ
    Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(34):2389-93. PubMed ID: 23158659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced p21(WAF1/CIP1) expression and p53 mutation in hepatocellular carcinomas.
    Hui AM; Kanai Y; Sakamoto M; Tsuda H; Hirohashi S
    Hepatology; 1997 Mar; 25(3):575-9. PubMed ID: 9049201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced p21(WAF1/CIP1) expression is an early event in gallbladder carcinogenesis and is of prognostic significance for patients with carcinomas of the gallbladder.
    Li X; Hui AM; Shi YZ; Takayama T; Makuuchi M
    Hum Pathol; 2001 Aug; 32(8):771-7. PubMed ID: 11521218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced expression of the CDK inhibitor p27(KIP1) in rat two-stage bladder carcinogenesis and its association with expression profiles of p21(WAF1/Cip1) and p53.
    Lee CC; Ichihara T; Yamamoto S; Wanibuchi H; Sugimura K; Wada S; Kishimoto T; Fukushima S
    Carcinogenesis; 1999 Sep; 20(9):1697-708. PubMed ID: 10469613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
    Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of p21(WAF1/CIP1) and p53 proteins in gastric carcinoma: its relationships with cell proliferation activity and prognosis.
    Liu XP; Tsushimi K; Tsushimi M; Kawauchi S; Oga A; Furuya T; Sasaki K
    Cancer Lett; 2001 Sep; 170(2):183-9. PubMed ID: 11463497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and alteration of p53 and p21(waf1/cip1) influence the sensitivity of chemoradiation therapy for esophageal cancer.
    Shimoyama S; Konishi T; Kawahara M; Aoki F; Harada N; Shimizu S; Murakami T; Kaminishi M
    Hepatogastroenterology; 1998; 45(23):1497-504. PubMed ID: 9840093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival.
    Aaltomaa S; Lipponen P; Ala-Opas M; Eskelinen M; Syrjänen K; Kosma VM
    Br J Cancer; 1999 Aug; 80(12):2001-7. PubMed ID: 10471053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of p53, p21(Waf1/Cip1) and TGF-beta(3) immunohistochemical staining in Bowen's disease.
    Kawakami T; Soma Y; Mizoguchi M; Saito R
    Dermatology; 2001; 202(1):9-15. PubMed ID: 11244221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WAF1/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium.
    Lukas J; Groshen S; Saffari B; Niu N; Reles A; Wen WH; Felix J; Jones LA; Hall FL; Press MF
    Am J Pathol; 1997 Jan; 150(1):167-75. PubMed ID: 9006333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear accumulation of p53 correlates significantly with clinical features and inversely with the expression of the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) in pancreatic cancer.
    Harada N; Gansauge S; Gansauge F; Gause H; Shimoyama S; Imaizumi T; Mattfeld T; Schoenberg MH; Beger HG
    Br J Cancer; 1997; 76(3):299-305. PubMed ID: 9252195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.